![](/img/cover-not-exists.png)
Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial
Dréno, Brigitte, Kunstfeld, Rainer, Hauschild, Axel, Fosko, Scott, Zloty, David, Labeille, Bruno, Grob, Jean-Jacques, Puig, Susana, Gilberg, Frank, Bergström, Daniel, Page, Damian R, Rogers, Gary, SchVolume:
18
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(17)30072-4
Date:
March, 2017
File:
PDF, 360 KB
english, 2017